Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 6:00 PM ET

Date/Time Source News Release
03/07/2025 04:05 PM EST GlobeNewswire Oncternal Therapeutics Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
10/22/2024 09:00 AM EDT GlobeNewswire Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
09/12/2024 09:00 AM EDT GlobeNewswire Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives
08/08/2024 04:01 PM EDT GlobeNewswire Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
08/01/2024 04:05 PM EDT GlobeNewswire Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results
07/15/2024 08:00 AM EDT GlobeNewswire Oncternal Announces Enrollment Completed and Dosing Initiated for Sixth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
07/11/2024 04:05 PM EDT GlobeNewswire Oncternal Therapeutics to Present in JonesTrading Healthcare Summit
05/30/2024 04:05 PM EDT GlobeNewswire Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
05/09/2024 04:01 PM EDT GlobeNewswire Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
05/02/2024 04:05 PM EDT GlobeNewswire Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results
Page

Additional News

As of June 8, 2025 • 6:00 PM ET

Date/Time Source News Release
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Oncternal Therapeutics Inc.
11/06/2024 08:10 AM EST Zacks Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates
10/21/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Mon, Oct 21, 2024 as of 4:00 pm ET
09/13/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Fri, Sep 13, 2024 as of 10.00 am ET
09/12/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Thu, Sep 12, 2024 as of 4:00 pm ET
09/12/2024 10:09 AM EDT SeekingAlpha Oncternal plunges on portfolio shakeup
09/12/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Sep 12, 2024 as of 10.00 am ET
08/10/2024 01:46 AM EDT SeekingAlpha Oncternal Therapeutics, Inc. (ONCT) Q2 2024 Earnings Call Transcript
08/08/2024 05:30 PM EDT Zacks Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates
08/08/2024 04:13 PM EDT SeekingAlpha Oncternal Therapeutics GAAP EPS of -$2.89 beats by $0.14, revenue of $0.8M beats by $0.64M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.